Vaxcyte (PCVX) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.3
-1.88
-1.46
-1.04

Details

Expected EPS
-1.7775
Actual EPS
-2.3
Surprise EPS
-0.52
Surprise Percent
+29.4%

Description

Vaxcyte (PCVX) has reported earnings of -2.3 per share for Q2 2026.

0 Comments

Share your thoughts